Literature DB >> 20082382

A new Lamarckian genetic algorithm for flexible ligand-receptor docking.

Jan Fuhrmann1, Alexander Rurainski, Hans-Peter Lenhof, Dirk Neumann.   

Abstract

We present a Lamarckian genetic algorithm (LGA) variant for flexible ligand-receptor docking which allows to handle a large number of degrees of freedom. Our hybrid method combines a multi-deme LGA with a recently published gradient-based method for local optimization of molecular complexes. We compared the performance of our new hybrid method to two non gradient-based search heuristics on the Astex diverse set for flexible ligand-receptor docking. Our results show that the novel approach is clearly superior to other LGAs employing a stochastic optimization method. The new algorithm features a shorter run time and gives substantially better results, especially with increasing complexity of the ligands. Thus, it may be used to dock ligands with many rotatable bonds with high efficiency. Copyright 2010 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2010        PMID: 20082382     DOI: 10.1002/jcc.21478

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  38 in total

1.  Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression.

Authors:  Bilal Bin Hafeez; Aditya Ganju; Mohammed Sikander; Vivek K Kashyap; Zubair Bin Hafeez; Neeraj Chauhan; Shabnam Malik; Andrew E Massey; Manish K Tripathi; Fathi T Halaweish; Nadeem Zafar; Man M Singh; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Mol Cancer Ther       Date:  2017-06-14       Impact factor: 6.261

Review 2.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

3.  Docking and molecular dynamics studies on triclosan derivatives binding to FabI.

Authors:  Xuyun Yang; Junrui Lu; Ming Ying; Jiangbei Mu; Peichun Li; Yue Liu
Journal:  J Mol Model       Date:  2017-01-07       Impact factor: 1.810

4.  A comparison of various optimization algorithms of protein-ligand docking programs by fitness accuracy.

Authors:  Liyong Guo; Zhiqiang Yan; Xiliang Zheng; Liang Hu; Yongliang Yang; Jin Wang
Journal:  J Mol Model       Date:  2014-06-17       Impact factor: 1.810

5.  EDGA: A Population Evolution Direction-Guided Genetic Algorithm for Protein-Ligand Docking.

Authors:  Boxin Guan; Changsheng Zhang; Jiaxu Ning
Journal:  J Comput Biol       Date:  2016-02-19       Impact factor: 1.479

6.  New functional aspects of the atypical protein tyrosine phosphatase VHZ.

Authors:  Vyacheslav I Kuznetsov; Alvan C Hengge
Journal:  Biochemistry       Date:  2013-10-29       Impact factor: 3.162

7.  Design, synthesis, in silico and biological evaluation of novel 2-(4-(4-substituted piperazin-1-yl)benzylidene)hydrazine carboxamides.

Authors:  Shikha Kumari; Chandra Bhushan Mishra; Danish Idrees; Amresh Prakash; Rajesh Yadav; Md Imtaiyaz Hassan; Manisha Tiwari
Journal:  Mol Divers       Date:  2016-12-30       Impact factor: 2.943

8.  Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2016-03-14       Impact factor: 3.850

9.  A Promiscuous CYP706A3 Reduces Terpene Volatile Emission from Arabidopsis Flowers, Affecting Florivores and the Floral Microbiome.

Authors:  Benoît Boachon; Yannick Burdloff; Ju-Xin Ruan; Rakotoharisoa Rojo; Robert R Junker; Bruno Vincent; Florence Nicolè; Françoise Bringel; Agnès Lesot; Laura Henry; Jean-Etienne Bassard; Sandrine Mathieu; Lionel Allouche; Ian Kaplan; Natalia Dudareva; Stéphane Vuilleumier; Laurence Miesch; François André; Nicolas Navrot; Xiao-Ya Chen; Danièle Werck-Reichhart
Journal:  Plant Cell       Date:  2019-10-18       Impact factor: 11.277

10.  New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of N-(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines.

Authors:  Tarana Umar; Shruti Shalini; Md Kausar Raza; Siddharth Gusain; Jitendra Kumar; Waqar Ahmed; Manisha Tiwari; Nasimul Hoda
Journal:  Medchemcomm       Date:  2018-08-20       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.